Cleared Traditional

Myomics Q (K211432) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K211432 · Phantomics, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2021
Decision
200d
Days
Class 2
Risk

K211432 is an FDA 510(k) clearance for the Myomics Q. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Phantomics, Inc. (Seoul, KR). The FDA issued a Cleared decision on November 23, 2021 after a review of 200 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Phantomics, Inc. devices

Submission Details

510(k) Number K211432 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 07, 2021
Decision Date November 23, 2021
Days to Decision 200 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
93d slower than avg
Panel avg: 107d · This submission: 200d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

KMC, Inc.
Milly Milly

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 788
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K211432.
X-Clever
K212137 · Lg Electronics.Inc · Dec 2021
ImplaStation
K210241 · Prodigident, Inc. · Dec 2021
PVmed Contouring Software
K210916 · Perception Vision Medical Technologies Ltd.Co. · Dec 2021
Intellijoint VIEW
K211876 · Intellijoint Surgical, Inc. · Nov 2021
MAMMOVISTA B.smart
K212621 · Siemens Medical Solutions USA, Inc. · Nov 2021
MiPACS HTML5 Web Viewer
K212984 · Lead Technologies, Inc. · Nov 2021